Xu Y - Search Results

1

Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research.

Wu X, Yang X, Liang Q, Xue X, Huang J, Wang J, Xu Y, Tong R, Liu M, Zhou Q, Shi J. Wu X, et al. Among authors: xu y. Eur J Med Chem. 2021 Dec 15;226:113842. doi: 10.1016/j.ejmech.2021.113842. Epub 2021 Sep 11. Eur J Med Chem. 2021. PMID: 34536672 Review.

2

Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.

Wu X, Xu Y, Jin L, Wang X, Zhu H, Xie Y. Wu X, et al. Among authors: xu y. Front Med (Lausanne). 2021 Jun 24;8:670744. doi: 10.3389/fmed.2021.670744. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34249969 Free PMC article.

3

Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects.

Wu X, Huang J, Wang J, Xu Y, Yang X, Sun M, Shi J. Wu X, et al. Among authors: xu y. Front Pharmacol. 2021 Aug 17;12:707491. doi: 10.3389/fphar.2021.707491. eCollection 2021. Front Pharmacol. 2021. PMID: 34489700 Free PMC article. Review.

4

Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment.

Wu X, Wang J, Liang Q, Tong R, Huang J, Yang X, Xu Y, Wang W, Sun M, Shi J. Wu X, et al. Among authors: xu y. Biomed Pharmacother. 2022 Jul;151:113116. doi: 10.1016/j.biopha.2022.113116. Epub 2022 May 19. Biomed Pharmacother. 2022. PMID: 35598365 Free article. Review.

5

Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment.

Wu X, Xu Y, Liang Q, Yang X, Huang J, Wang J, Zhang H, Shi J. Wu X, et al. Among authors: xu y. Front Pharmacol. 2022 May 9;13:875372. doi: 10.3389/fphar.2022.875372. eCollection 2022. Front Pharmacol. 2022. PMID: 35614940 Free PMC article. Review.

6

Efficacy and safety of Chinese herbal medicine in the treatment of chronic pruritus: A systematic review and meta-analysis of randomized controlled trials.

Wang J, Chen Y, Yang X, Huang J, Xu Y, Wei W, Wu X. Wang J, et al. Among authors: xu y. Front Pharmacol. 2023 Jan 12;13:1029949. doi: 10.3389/fphar.2022.1029949. eCollection 2022. Front Pharmacol. 2023. PMID: 36712693 Free PMC article.

7

Jiawei guomin decoction regulates the degranulation of mast cells in atopic dermatitis mice via the HIS/PAR-2 pathway.

Huang JL, Xu YH, Yang XW, Wang J, Zhu Y, Wu XB. Huang JL, et al. Among authors: xu yh. J Ethnopharmacol. 2024 Mar 1;321:117485. doi: 10.1016/j.jep.2023.117485. Epub 2023 Nov 24. J Ethnopharmacol. 2024. PMID: 38008276

8

Recent advances in anti-inflammation via AMPK activation.

Xu Y, Bai L, Yang X, Huang J, Wang J, Wu X, Shi J. Xu Y, et al. Heliyon. 2024 Jun 26;10(13):e33670. doi: 10.1016/j.heliyon.2024.e33670. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040381 Free PMC article. Review.

9

Metabolomics Analysis of Laparoscopic Surgery Combined with Wuda Granule to Promote Rapid Recovery of Patients with Colorectal Cancer Using UPLC/Q-TOF-MS/MS.

Wang T, Xu Y, Chen Q, Zheng W, Wang J, Zeng H, Wu Y, Cao L, Chen Z. Wang T, et al. Among authors: xu y. Evid Based Complement Alternat Med. 2020 Feb 13;2020:5068268. doi: 10.1155/2020/5068268. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32104193 Free PMC article.

10

Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.

Chen C, Yao X, Xu Y, Zhang Q, Wang H, Zhao L, Wen G, Liu Y, Jing L, Sun X. Chen C, et al. Among authors: xu y. J Ethnopharmacol. 2019 Jun 28;238:111878. doi: 10.1016/j.jep.2019.111878. Epub 2019 Apr 13. J Ethnopharmacol. 2019. PMID: 30986521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,506 results

Search Page

Filters